tiprankstipranks
Trending News
More News >
Neurogene (NGNE)
NASDAQ:NGNE
US Market

Neurogene (NGNE) Income Statement

Compare
583 Followers

Neurogene Income Statement

Last quarter (Q3 2025), Neurogene's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Neurogene's net income was $-20.95M. See Neurogene’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 925.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -2.32M$ -3.26M$ -3.20M$ -42.26M$ -1.82M
Operating Expenses
$ 80.28M$ 52.32M$ 53.32M$ 8.27M$ 39.73M
Depreciation and Amortization
$ 3.25M$ 3.30M$ 3.20M$ 947.00K$ 1.82M
EBITDA
$ -71.89M$ -52.29M$ -51.99M$ -49.59M$ -31.46M
Operating Income
$ -82.61M$ -55.58M$ -56.52M$ -50.53M$ -41.55M
Other Income/Expenses
$ 7.46M$ 19.27M$ 1.33M$ 17.00K$ 8.28M
Pretax Income
$ -75.14M$ -36.32M$ -55.19M$ -50.52M$ -33.28M
Net Income
$ -75.14M$ -36.32M$ -55.19M$ -50.52M$ -33.28M
Per Share Metrics
Basic EPS
$ -4.28$ -2.83$ -4.30$ -0.92$ -0.64
Diluted EPS
$ -4.28$ -2.83$ -4.30$ -0.92$ -0.64
Weighted Average Shares Outstanding
17.57M 12.82M 12.82M 55.04M 51.83M
Weighted Average Shares Outstanding (Diluted)
17.57M 12.82M 12.82M 55.04M 51.83M
Currency in USD

Neurogene Earnings and Revenue History